Crossmark

An application of PRECIS-2 to evaluate trial design in a pilot cluster randomised controlled trial of a community-based smoking cessation intervention for women living in disadvantaged areas of Ireland

Crossref DOI link: https://doi.org/10.1186/s40814-022-00969-6

Published Online: 2022-01-25

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Darker, Catherine

Loudon, Kirsty

O’Connell, Nicola

Castello, Stefania

Burke, Emma

Vance, Joanne

Reynolds, Caitriona

Buggy, Aine

Dougall, Nadine

Williams, Pauline

Dobbie, Fiona

Bauld, Linda

Hayes, Catherine B. http://orcid.org/0000-0002-1576-4623
Funding

Funding for this research was provided by:

health research board (DIFA-2017-048)
License Information

Text and Data Mining valid from 2022-01-25

Version of Record valid from 2022-01-25
More Information

Article History

Received: 27 July 2021

Accepted: 5 January 2022

First Online: 25 January 2022

Declarations

:

: The study was approved by the School of Medicine Research Ethics Committee, Trinity College Dublin (Reference number: 20170404).

: Not applicable.

: CBH reports grants from HRB and Enterprise Ireland during the conduct of the study. CD reports grants from HRB during the conduct of the study.

Document is current

Any future updates will be listed below